Characteristics of tobacco-related lung diseases in Fukuoka Prefecture, Japan: A prospective, multi-institutional, observational study

• Published in: Respiratory investigation Vol. 58; no. 1; pp. 74 - 80
• Main Authors: Ogata-Suetsugu, Saiko, Hamada, Naoki, Tsuda, Toru, Takata, Shohei, Kitasato, Yasuhiko, Inoue, Naoyuki, Nagata, Nobuhiko, Yatera, Kazuhiro, Mukae, Hiroshi, Yoshii, Chiharu, Hoshino, Tomoaki, Fujita, Masaki, Watanabe, Kentaro, Tokunaga, Shoji, Nakanishi, Yoichi
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.01.2020
• Subjects: Chronic obstructive pulmonary disease; Combined pulmonary fibrosis and emphysema; Idiopathic interstitial pneumonia; Registry study; Tobacco smoking; FOLD; mMRC; BNP; Tobacco smoking; Registry study; Combined pulmonary fibrosis and emphysema; NSIP; KL-6; LAMA; VC; CT; IIP; FVC; CPFE; NT-proBNP; Idiopathic interstitial pneumonia; DNA; ICS/LABA; Chronic obstructive pulmonary disease; FEV1; HRCT; IPF; COPD
• ISSN: 2212-5345; 2212-5353
• DOI: 10.1016/j.resinv.2019.10.002

Tobacco smoking causes a variety of smoking-related diseases, death, and economic damage. Despite targeted anti-smoking campaigns, tobacco-related deaths are expected to increase in Japan. We investigated the current state of non-cancerous lung diseases such as idiopathic interstitial pneumonias (IIPs), chronic obstructive pulmonary disease (COPD), and combined pulmonary fibrosis and emphysema (CPFE), which are known to be highly related to tobacco smoking. This prospective multi-institutional observational study involved 29 major hospitals within the Fukuoka Prefecture area (Fukuoka tobacco-related lung disease registry study group). Patients diagnosed with IIPs, including CPFE and COPD, registered from September 1, 2013 to April 30, 2016 were included. Clinical background information, laboratory and pulmonary function test results, findings of imaging tests, including chest radiography and chest computed tomography, and DNA isolated from peripheral blood were collected from each patient. Follow-up surveillance involved collection of data regarding the exacerbation of disease and death until 5 years of registration. In the present study, we report the baseline characteristics of the patients registered in this surveillance study. Overall, 1016 patients (524 with IIPs, including 145 CPFE and 492 with COPD) were enrolled. Among the patients with COPD, 96.8% were current or former smokers. Among the patients with IIPs, 69.9% were current or former smokers. This study revealed the current status of lung diseases potentially related to tobacco smoking in Fukuoka Prefecture. Both COPD and CPFE were highly related to tobacco smoking, whereas 30% of patients with IIPs had never smoked.